Literature DB >> 7657611

Alternative translation initiation of the Moloney murine leukemia virus mRNA controlled by internal ribosome entry involving the p57/PTB splicing factor.

S Vagner1, A Waysbort, M Marenda, M C Gensac, F Amalric, A C Prats.   

Abstract

Moloney murine leukemia virus (Mo-MuLV) genomic mRNA codes for two gag precursors by alternative initiations of translation. An AUG codon governs the synthesis of the retroviral capsid proteins precursor, whereas a CUG codon directs the synthesis of a glycosylated cell surface antigen, the gross cell surface antigen. Control of the relative synthesis of the two precursors is crucial for MuLV infectivity and pathology. Furthermore, the MuLV mRNA leader sequence is very long and should inhibit translation according to the classical scanning model. This suggests a different translation initiation mechanism allowing gag efficient expression. We demonstrate, by using bicistronic vectors expressed in COS-7 cells, that the Mo-MuLV mRNA leader drives translation initiation by internal ribosome entry. We have localized the internal ribosome entry site (IRES) between the two initiation codons. This 126 nucleotide long IRES implies an oligopyrimidine tract located 45 nucleotides upstream of AUG codon. UV cross-linking and affinity chromatography experiments show that the PTB/p57 splicing factor specifically interacts with this oligopyrimidine tract. The MuLV IRES controls alternative translation initiation by activating the capsid protein precursor expression. This gag translational enhancer could exist in other retroviruses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7657611     DOI: 10.1074/jbc.270.35.20376

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Differentiation-induced internal translation of c-sis mRNA: analysis of the cis elements and their differentiation-linked binding to the hnRNP C protein.

Authors:  O Sella; G Gerlitz; S Y Le; O Elroy-Stein
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

2.  Effect of intercistronic length on internal ribosome entry site (IRES) efficiency in bicistronic mRNA.

Authors:  J Attal; M C Theron; C Puissant; L M Houdebine
Journal:  Gene Expr       Date:  1999

Review 3.  Destiny of unspliced retroviral RNA: ribosome and/or virion?

Authors:  Melinda Butsch; Kathleen Boris-Lawrie
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Rous sarcoma virus translation revisited: characterization of an internal ribosome entry segment in the 5' leader of the genomic RNA.

Authors:  C Deffaud; J L Darlix
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Characterization of two distinct RNA domains that regulate translation of the Drosophila gypsy retroelement.

Authors:  Corinne Ronfort; Sylvain De Breyne; Virginie Sandrin; Jean-Luc Darlix; Théophile Ohlmann
Journal:  RNA       Date:  2004-03       Impact factor: 4.942

Review 6.  Searching for IRES.

Authors:  Stephen D Baird; Marcel Turcotte; Robert G Korneluk; Martin Holcik
Journal:  RNA       Date:  2006-09-06       Impact factor: 4.942

7.  Recombination in the 5' leader of murine leukemia virus is accurate and influenced by sequence identity with a strong bias toward the kissing-loop dimerization region.

Authors:  J G Mikkelsen; A H Lund; M Duch; F S Pedersen
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

8.  An unusual internal ribosomal entry site of inverted symmetry directs expression of a potato leafroll polerovirus replication-associated protein.

Authors:  Hannah Miriam Jaag; Lawrence Kawchuk; Wolfgang Rohde; Rainer Fischer; Neil Emans; Dirk Prüfer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-30       Impact factor: 11.205

9.  Translation initiation factors are not required for Dicistroviridae IRES function in vivo.

Authors:  Nilsa Deniz; Erik M Lenarcic; Dori M Landry; Sunnie R Thompson
Journal:  RNA       Date:  2009-03-19       Impact factor: 4.942

10.  Feline immunodeficiency virus OrfA is distinct from other lentivirus transactivators.

Authors:  Udayan Chatterji; Aymeric de Parseval; John H Elder
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.